Adicet Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Adicet Bio generated cash of -$93,717,000, which is less than the previous year. Cash used in financing activities reached the amount of $236,000 last year. Net change in cash is therefore -$97,945,000.
Cash Flow
| 2014 | 25.47M | -2.80M | -14.30M |
|---|---|---|---|
| 2015 | 25.05M | -85.92M | 70.53M |
| 2016 | 8.34M | -8.97M | 0 |
| 2017 | -11.55M | -44K | 64.94M |
| 2018 | -18.18M | -16.05M | 11.04M |
| 2019 | -27.88M | -47.93M | 76.94M |
| 2020 | -41.55M | 115.21M | 303K |
| 2021 | -51.05M | -2.79M | 242.68M |
| 2022 | -44.76M | -16.78M | 41.50M |
| 2023 | -93.71M | -4.46M | 236K |
ACET Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 257.65M | 277.69M | 88.85M | 14.88M | 13.75M | 36.94M | 22.87M | 75.70M | 24.35M | 34.52M |
Operating activities | ||||||||||
Net income | -142.65M | -69.79M | -61.99M | -36.67M | -28.13M | -9.29M | -33.77M | 33.48M | 29M | 22.32M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 6.09M | 2.57M | 1.53M | 1.22M | 1.23M | 1.22M | 5K | 11.84M | 8.09M | 6.94M |
Stock-based compensation expense | 20.25M | 17.12M | 12.51M | 5.26M | 1.17M | 0 | 470K | 0 | 0 | 0 |
| Deferred income tax benefit | 20.25M | 17.12M | 12.51M | 5.26M | 1.17M | 0 | 470K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 185K | -30K | 0 | 0 | 0 | -6.14M | -44.18M | -19.4M | -14.98M |
Inventories | 0 | 0 | 2.01M | 0 | 0 | 0 | -2.48M | -229K | -7.76M | 1.63M |
Accounts payable | -1.68M | 1.71M | 1.13M | -814K | 527K | -282K | 1.39M | 8.13M | 5.21M | -3.22M |
Cash generated by operating activities | -93.71M | -44.76M | -51.05M | -41.55M | -27.88M | -18.18M | -11.55M | 8.34M | 25.05M | 25.47M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -5.7M | -76.07M | -15.18M | -2.03M | -34K | -2.72M | -108K |
Investments In Property Plant And Equipment | -4.46M | -16.78M | -13.04M | -990K | -1.07M | -876K | -44K | -617K | -1.14M | -1.02M |
Acquisitions Net | 0 | 0 | 0 | 64.11M | 118K | 0 | 0 | 0 | -86.14M | 0 |
Cash generated by investing activities | -4.46M | -16.78M | -2.79M | 115.21M | -47.93M | -16.05M | -44K | -8.97M | -85.92M | -2.80M |
Financing activities | ||||||||||
Common Stock Issued | 386K | 43.36M | 238.12M | 144K | 76.94M | 90.91M | 64.94M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -150K | 0 | 0 | 0 | 0 | 0 | -55.68M | 0 | -34.02M | -42.89M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -84K | 0 | 0 | 0 | -23.69M |
Cash used in financing activities | 236K | 41.50M | 242.68M | 303K | 76.94M | 11.04M | 64.94M | 0 | 70.53M | -14.30M |
Net Change In Cash | -97.94M | -20.03M | 188.83M | 73.96M | 1.13M | -23.19M | 30.47M | -8.87M | 9.66M | 8.36M |
Cash at end of period | 159.71M | 257.65M | 277.69M | 88.85M | 14.88M | 13.75M | 53.34M | 66.82M | 34.02M | 42.89M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |